Levonorgestrel/Ethinylestradiol

左炔诺孕酮/炔雌醇

Report date: 2024/04/24 17:00:11

Base Information

Drug NameLevonorgestrel/Ethinylestradiol
Drug Alias NameEthinylestradiol and LevonorgestrelEthinylestradiol+LevonorgestrelEthinylestradiol-LevonorgestrelEthinylestradiol/LevonorgestrelEthinyl Estradiol/Levonorgestrel +[40] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionEstrogen receptors agonistsProgesterone receptor agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsContraceptionMigraine Disorders
Global Approved IndicationsContraception
Approved Indications in ChinaContraception
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsGermany +[7] 
CombinationsYes Ethinyl EstradiolLevonorgestrel
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer IncSchering - Plough SaMeda Ab +[6] 
China Registration ClassN/A

Develop Information

Active CompaniesAfaxys Pharma LLCAska Pharmaceutical Co LtdLeiden University Medical Center +[6] 
Inactive CompaniesBayer AGChina Resources Zizhu Pharmaceutical Co LtdRunhe Biology Medicine Technology (Shantou) Co Ltd +[4] 
Active IndicationsContraceptionMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeG03AA07G03AB03
Related LinksN/A